Millions of Americans on Original Medicare face a cost-sharing structure that charges them 20% of the Medicare-approved amount for most doctor visits and outpatient services, with no annual ceiling on what they might owe. For 2025, the Part B deductible is set at $257, and once that threshold is met, the 20% coinsurance kicks in on nearly every physician bill. Unlike Medicare Advantage plans, which are required to set a yearly out-of-pocket maximum, Original Medicare offers no such safety net unless a beneficiary carries supplemental coverage.
Why the 20% coinsurance without a cap hits harder each year
The financial exposure built into Original Medicare is not new, but it compounds as health care prices rise. After a beneficiary pays the annual Part B deductible, the federal program covers 80% of the Medicare-approved amount for most physician and clinician services. The remaining 20% falls on the patient. For a single expensive procedure or a year of ongoing specialist care, that share can grow quickly, and nothing in the program’s design stops it from climbing.
The statutory roots of this arrangement trace back to Section 1833 of the Social Security Act, which establishes Part B payment rules. Federal regulations in 42 CFR 410.152 spell out the 20% coinsurance requirement across multiple outpatient and provider settings. These are not recent policy choices. They are embedded in the program’s legal architecture, and Congress has not added an annual out-of-pocket limit for Original Medicare beneficiaries.
That gap matters most for people without a backstop. Beneficiaries who hold Medigap policies, Medicaid dual eligibility, or employer-sponsored retiree coverage can offset the open-ended exposure. Those who lack any supplemental plan absorb the full 20% on every covered service, no matter how high the total climbs in a given year. The CMS fact sheet on 2025 premiums and deductibles confirms the latest cost parameters but does not signal any structural change to this arrangement. As a result, people who rely solely on Part B must budget around an open-ended liability that can be difficult to predict.
The absence of a ceiling also interacts with other parts of Medicare’s cost structure. Beneficiaries still pay monthly Part B premiums and may owe deductibles or coinsurance for hospital care, skilled nursing, and other services. Official Medicare cost information lays out these separate charges, but the program does not aggregate them into a single, guaranteed maximum. For someone managing chronic illness, that means every new diagnostic test, infusion, or outpatient surgery adds another layer of coinsurance on top of already substantial fixed costs.
How the absence of a spending cap shapes enrollment decisions
The contrast with Medicare Advantage is stark. Medicare Advantage plans are required to include a yearly out-of-pocket limit, giving enrollees a defined worst-case scenario for annual spending. Original Medicare provides no equivalent protection on its own. That difference drives a significant share of the choices beneficiaries make during open enrollment each fall, particularly among people with known health needs who are trying to avoid catastrophic bills.
One hypothesis worth tracking is how this design nudges people toward supplemental coverage. As the Part B deductible edges upward year after year and no spending cap materializes, Medigap uptake could accelerate most sharply among beneficiaries who already have retiree coverage or who live in regions with higher health care costs. If that pattern holds, supplemental enrollment rates would diverge measurably by geography and prior insurance status. No publicly available CMS enrollment file currently isolates this effect at the beneficiary level, but the structural incentive is clear. People in expensive metro areas or those accustomed to employer-style coverage are better positioned to shop for and afford a Medigap policy, while lower-income enrollees without Medicaid may remain exposed.
The choice between staying in Original Medicare without a cap and moving into Medicare Advantage with a defined maximum is rarely simple. Medicare Advantage plans can trade lower, more predictable out-of-pocket exposure for narrower provider networks, prior authorization rules, and plan-level benefit changes from year to year. Some beneficiaries prioritize access to specific specialists or academic medical centers and accept uncapped coinsurance as the price of that freedom. Others, especially those on fixed incomes, place a higher value on having a clear upper bound on annual spending even if it means switching doctors.
Policy debates around Medicare’s future increasingly reflect this tension. Proposals to add an out-of-pocket maximum to Original Medicare would align it more closely with employer plans and Medicare Advantage, but they would also shift some costs to the federal budget or require new financing. Until such a change occurs, the 20% coinsurance without a cap will continue to shape how beneficiaries evaluate risk, shop for supplemental coverage, and decide between traditional Medicare and private plan options.
